Sreedhar Subramanian

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 281 citations · Full text

Veterinary Medicine, Immunology, Gastroenterology +16

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

Peter M. Irving, Tariq Iqbal, Chuka Nwokolo et al. · Inflammatory Bowel Diseases · 2018 · 158 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

Christina Kapizioni, R Desoki, Danielle Lam et al. · Journal of Crohn s and Colitis · 2023 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

Craig Mowat, Ian Arnott, Aiden Cahill et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 106 citations · Full text

Medicine, Pharmacotherapy, Surgery +14

Replication of Colonic Crohn's Disease Mucosal <i>Escherichia coli</i> Isolates within Macrophages and Their Susceptibility to Antibiotics

Sreedhar Subramanian, Carol L. Roberts, C. Anthony Hart et al. · Antimicrobial Agents and Chemotherapy · 2007 · 92 citations

Life Sciences, Infectious Diseases, Microbiology +17